AB
Arpeggio Biosciences, Inc.
SEC filingOther Technology · Boulder, CO
Amount raised$20Msold at filing
Total offering$35.3M$15.3M still open
Investors in the raise12count reported to the SEC
FiledNov 24, 2025first sale Nov 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Timothy G. ReadExecutive Officer
Laura G. NorrisExecutive Officer
David G. AllisonDirector
Joseph G. AzofeifaExecutive Officer, Director
Mira G. ChaurushiyaDirector
Samuel G. KintzDirector
Aaron G. RoystonDirector
Executive officers, directors and promoters as listed on the Form D.